BYZINSA Trademark

Trademark Overview


On Friday, April 24, 2020, a trademark application was filed for BYZINSA with the United States Patent and Trademark Office. The USPTO has given the BYZINSA trademark a serial number of 79286337. The federal status of this trademark filing is REGISTERED as of Tuesday, October 27, 2020. This trademark is owned by NOVARTIS AG. The BYZINSA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
byzinsa

General Information


Serial Number79286337
Word MarkBYZINSA
Filing DateFriday, April 24, 2020
Status700 - REGISTERED
Status DateTuesday, October 27, 2020
Registration Number6182302
Registration DateTuesday, October 27, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 11, 2020

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 5, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSandoz AG
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Sunday, January 28, 2024CHANGE OF OWNER RECEIVED FROM IB
Wednesday, November 3, 2021LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Thursday, October 28, 2021LIMITATION OF GOODS RECEIVED FROM IB
Sunday, January 3, 2021NOTIFICATION PROCESSED BY IB
Monday, December 14, 2020FINAL DISPOSITION NOTICE SENT TO IB
Sunday, December 13, 2020FINAL DISPOSITION PROCESSED
Thursday, November 26, 2020GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, October 27, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, August 11, 2020PUBLISHED FOR OPPOSITION
Friday, August 7, 2020NOTIFICATION PROCESSED BY IB
Wednesday, July 22, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 22, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 22, 2020NOTICE OF PUBLICATION
Thursday, July 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, July 5, 2020ASSIGNED TO EXAMINER
Tuesday, June 9, 2020APPLICATION FILING RECEIPT MAILED
Friday, June 5, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 4, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, May 28, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB